AGLCX
Price
$6.48
Change
-$0.04 (-0.61%)
Updated
Jun 26 closing price
Net Assets
547.07M
RNPAX
Price
$67.24
Change
-$0.11 (-0.16%)
Updated
Jun 26 closing price
Net Assets
171.51B
Interact to see
Advertisement

AGLCX vs RNPAX

AGLCX vs RNPAX Comparison Chart in %
View a ticker or compare two or three
VS
AGLCX vs. RNPAX commentary
Jun 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGLCX is a Hold and RNPAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPAX has more cash in the bank: 172B vs. AGLCX (547M). RNPAX pays higher dividends than AGLCX: RNPAX (0.36) vs AGLCX (0.00). AGLCX was incepted earlier than RNPAX: AGLCX (24 years) vs RNPAX (24 years). AGLCX (2.10) is less costly to investors than RNPAX (1.49). AGLCX is a more actively managed with annual turnover of: 68.00 vs. RNPAX (23.00). RNPAX has a lower initial minimum investment than AGLCX: RNPAX (250) vs AGLCX (2500). RNPAX annual gain was more profitable for investors over the last year : 6.83 vs. AGLCX (-8.04). RNPAX return over 5 years is better than : 7.84 vs. AGLCX (-43.16).
AGLCXRNPAXAGLCX / RNPAX
Total Expense Ratio2.101.49141%
Annual Report Gross Expense Ratio2.101.49141%
Fund Existence24 years24 years-
Gain YTD3.6574.37884%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets547M172B0%
Annual Yield % from dividends0.000.36-
Returns for 1 year-8.046.83-118%
Returns for 3 years-6.4634.05-19%
Returns for 5 years-43.167.84-550%
Returns for 10 years-27.65106.56-26%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FHTX4.220.19
+4.71%
Foghorn Therapeutics
ELV395.187.86
+2.03%
Elevance Health
PFBC104.820.08
+0.08%
Preferred Bank
GDS29.25-0.08
-0.27%
GDS Holdings Limited
PLSM5.66-0.24
-4.07%
Pulsenmore Ltd.